Photocure Highlights
Optimized TURBT
The Extent of TURBT in MIBC
At EAU 2025, Dr. Marco Moschini addresses the debate on the required extent of TURBT for muscle-invasive bladder cancer (MIBC). He explains that the surgical approach depends on the patient's treatment plan. Transcript Interviewer Welcome everybody to the EAU 25 in...
Managing Synchronous Upper and Lower Tract Urothelial Carcinoma
At EAU 2025, Dr. Alexandra Masson-Lecomte, a leading expert on the urothelial cancer guidelines, addresses the complex question of how to manage synchronous upper and lower tract urothelial cancer. Focusing on patients with high-grade urothelial cancer, she details a...
Do we need TURBT in MIBC? – Part 2
This UROwebinar tackles a central uro-oncology debate: "Do we need TURBT in MIBC?" As advancements in MRI for bladder cancer challenge traditional methods, this session features key opinion leaders presenting opposing views on whether a full TURBT can be replaced by a...
The Role of ctDNA in Urothelial Cancer
Marie-Pier St-Laurent from Vancouver, urologic oncologist, and David Anderer, an urologist from Vienna, Austria, discussed the role of ctDNA in urothelial cancer research. Dr. St-Laurent explained that ctDNA can be used in tumor-informed or tumor-naive approaches,...